| Gene symbol | TP53 | Synonyms | BCC7, BMFS5, LFS1, P53, TRP53 | Type of gene | protein-coding |
| Chromosome | 17 | Map location | 17p13.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | tumor protein p53 | ||||
| GTO ID | GTC1331 |
| Trial ID | NCT00967512 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | P53 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | Aezea|Cenersen|EL625|Ol(1)p53 |
| Co-treatment | idarubicin|cytarabine |
| Phase | Phase2 |
| Recruitment status | Withdrawn |
| Title | Aezea (Cenersen) in Combination With Chemotherapy for Treatment of Acute Myelogenous Leukemia Subjects >=55 Years of Age With No Response to Single Frontline Induction Course in a Randomized Double-Blind Placebo-Controlled Multi-Center Study |
| Year | 2009 |
| Country | United States |
| Company sponsor | Eleos, Inc. |
| Other ID(s) | ELP1020|2008-002160-34 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||
|
|||||||